publication date: Jul. 24, 2020

NCI steps in to pay trainees whose funding from nonprofits fails to materialize

By Alexandria Carolan

This story is part of The Cancer Letter’s ongoing coverage of COVID-19’s impact on oncology. Our full coverage of SARS-CoV2 is available here.

If non-profit organizations are unable to make good on their commitments to trainees, NCI is prepared to fill that gap, NCI Director Ned Sharpless said during a July 22 virtual meeting of the American Association for Cancer Research on COVID-19 and Cancer.

Fundraising at nearly all nonprofits has been affected by the COVID-19 pandemic, making it impossible for some to fund grants they had previously approved.

“The NCI has heard from a number of these foundations and external scientists that some postdoctoral fellowships are at risk, because of decreased fundraising during the pandemic, and we are eager to step into this breach and solve this problem,” Sharpless said.

A recent NCI Notice of Special Interest specifies that NCI will provide administrative supplements to cover the salary for postdoctoral fellows whose stipends have come from a non-profit that cannot supply future funding because of the COVID-19 pandemic.

“We’re working to keep the cancer research enterprise operating to the fullest extent possible,” Sharpless said. “Tremendous progress has been made in cancer, and, as you know, the pandemic has put cancer research on hold for many of you. But the NCI is here to help make sure normal operations resume in terms of cancer research, as quickly as possible.”

The Notice of Special Interest enables NCI-funded principal investigators whose postdoctoral fellows have temporarily lost stipends from other entities to ask for supplements to … Continue reading NCI steps in to pay trainees whose funding from nonprofits fails to materialize

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.